Chronische Infektion, Inflammation und koronare Herzkrankheit

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal für Kardiologie - Austrian Journal of Cardiology

• Publication date

  2004-12-03

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased Risk of Atherosclerosis Is Confined to CagA-Positive Helicobacter pylori Strains: Prospective Results From the Bruneck Study

  2003cited by this paper
• Statin Therapy Interacts With Cytomegalovirus Seropositivity and High C-Reactive Protein in Reducing Mortality Among Patients With Angiographically Significant Coronary Disease

  2003cited by this paper
• Cytomegalovirus seropositivity, infectious burden, and coronary artery disease.

  2003cited by this paper
• Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.

  2003cited by this paper
• Inflammation and coronary artery disease.

  2003cited by this paper
• Chronic infection and coronary artery disease.

  2003cited by this paper
• Hepatitis A IgG seropositivity and coronary atherosclerosis assessed by angiography.

  2003cited by this paper
• Hepatitis A virus seropositivity and coronary artery disease.

  2003cited by this paper
• C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction.

  2003cited by this paper
• Influenza Infection Exerts Prominent Inflammatory and Thrombotic Effects on the Atherosclerotic Plaques of Apolipoprotein E–Deficient Mice

  2003cited by this paper
• Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

  2003cited by this paper
• Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial.

  2003cited by this paper
• C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women

  2003cited by this paper
• Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

  2003cited by this paper
• Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.

  2002cited by this paper
• Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention.

  2002cited by this paper
• Cytokine gene polymorphisms and development of CAD associated with CP infection.

  2002cited by this paper
• Association Between Influenza Vaccination and Reduced Risk of Brain Infarction

  2002cited by this paper
• Helicobacter pylori infection, infectious burden, and coronary artery disease.

  2002cited by this paper
• Immunopathogenesis of atherosclerosis.

  2002cited by this paper
• Interleukin-1 receptor antagonist gene polymorphism, infectious burden, and coronary artery disease.

  2002cited by this paper
• Influenza virus infection, infectious burden, and atherosclerosis.

  2002cited by this paper
• Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events.

  2002cited by this paper
• Effect of Treatment for Chlamydia pneumoniae and Helicobacter pylori on Markers of Inflammation and Cardiac Events in Patients With Acute Coronary Syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA)

  2002cited by this paper
• Porphyromonas gingivalis Infection Accelerates the Progression of Atherosclerosis in a Heterozygous Apolipoprotein E–Deficient Murine Model

  2002cited by this paper
• Prognostic significance of immune activation after acute coronary syndromes.

  2002cited by this paper
• Impact of Infectious Burden on Extent and Long-Term Prognosis of Atherosclerosis

  2002cited by this paper
• Mycoplasma pneumoniaehigh IgA titer but not IgG predicts increased hazard of death or myocardial infarction among patients with angiographically defined coronary artery disease

  2002cited by this paper
• Influenza Vaccine Pilot Study in Acute Coronary Syndromes and Planned Percutaneous Coronary Interventions: The FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study

  2002cited by this paper
• Influenza A and B IgG seropositivity and coronary atherosclerosis assessed by angiography.

  2002cited by this paper
• C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.

  2002cited by this paper
• Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial.

  2001cited by this paper
• Serum neopterin and activity of coronary artery disease.

  2001cited by this paper
• [Acute coronary syndromes: an update. II. Coronary revascularization and risk stratification].

  2001influential reference
• Prospective Study of Pathogen Burden and Risk of Myocardial Infarction or Death

  2001cited by this paper
• Chlamydia pneumoniae Infection in Circulating Human Monocytes Is Refractory to Antibiotic Treatment

  2001cited by this paper
• Impact of Viral and Bacterial Infectious Burden on Long-Term Prognosis in Patients With Coronary Artery Disease

  2001cited by this paper
• Relationship of Periodontal Disease to Carotid Artery Intima-Media Wall Thickness: The Atherosclerosis Risk in Communities (ARIC) Study

  2001cited by this paper
• [Acute coronary syndromes: an update. I. Pathogenesis and drug therapy].

  2001influential reference
• Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels.

  2000cited by this paper
• The possible role of hepatitis A virus in the pathogenesis of atherosclerosis.

  2000cited by this paper
• Association of Influenza Vaccination and Reduced Risk of Recurrent Myocardial Infarction

  2000influential reference
• Acute myocardial infarction and prior antibiotic use.

  2000cited by this paper
• Description and status of the azithromycin and coronary events study (ACES).

  2000influential reference
• The New England Journal

  2000cited by this paper
• Subgingival colonization by Porphyromonas gingivalis.

  2000cited by this paper
• Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease.

  2000cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.

  1999cited by this paper
• Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline.

  1999cited by this paper
• The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae.

  1999cited by this paper
• Does the mouth put the heart at risk?

  1999cited by this paper
• Antibiotics and risk of subsequent first-time acute myocardial infarction.

  1999cited by this paper
• Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

  1998cited by this paper
• Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction.

  1998cited by this paper
• Association of virulent Helicobacter pylori strains with ischemic heart disease.

  1998cited by this paper
• Prediction of coronary heart disease using risk factor categories.

  1998cited by this paper
• High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors.

  1998cited by this paper
• Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction.

  1998cited by this paper
• Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies

  1998cited by this paper
• Association of the oral flora with important medical diseases.

  1997cited by this paper
• Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group.

  1997cited by this paper
• Antioxidants and atherosclerotic heart disease.

  1997cited by this paper
• Rabbit model for Chlamydia pneumoniae infection

  1997cited by this paper
• Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor.

  1997cited by this paper
• Murine models of Chlamydia pneumoniae infection and atherosclerosis.

  1997cited by this paper
• Association of the oral flora with important medical diseases.

  1997cited by this paper
• Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease.

  1996cited by this paper
• Periodontal Disease and Cardiovascular Disease.

  1996cited by this paper
• Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities.

  1996cited by this paper
• Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy.

  1996cited by this paper
• Asymptomatic atherosclerosis in HIV-positive patients: A case-control ultrasound study.

  1995cited by this paper
• Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1995cited by this paper
• Interaction of human cytomegalovirus with p53: possible role in coronary restenosis.

  1995cited by this paper
• Molecular bases of the acute coronary syndromes.

  1995cited by this paper
• A bacterial sensitivity test to determine the effectiveness of minocycline HCI (Minocin), erythromycin (Erythrocin) and ampicillin (Ampicin) on the predominant microorganisms present in a diseased periodontium.

  1994cited by this paper
• Relation of Helicobacter pylori infection and coronary heart disease.

  1994cited by this paper
• A bacterial sensitivity test to determine the effectiveness of minocycline HCI (Minocin), erythromycin (Erythrocin) and ampicillin (Ampicin) on the predominant microorganisms present in a diseased periodontium.

  1994cited by this paper
• Cytomegalovirus DNA in arterial walls of patients with atherosclerosis

  1994cited by this paper
• Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis.

  1994cited by this paper
• Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

  1994cited by this paper
• Inflammation and Coronary Artery Disease

  1994cited by this paper
• Helicobacter pylori and peptic ulcer disease.

  1993cited by this paper
• Dental disease and risk of coronary heart disease and mortality.

  1993cited by this paper
• Herpes simplex virus and atherosclerosis.

  1993cited by this paper
• Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate.

  1993cited by this paper
• Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.

  1993cited by this paper
• Herpes simplex virus type I does not require productive infection to induce tissue factor in human umbilical vein endothelial cells.

  1993cited by this paper
• Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction.

  1993cited by this paper
• Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques.

  1992cited by this paper
• Herpes virus infection of endothelium: new insights into atherosclerosis.

  1992cited by this paper
• The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells

  1991cited by this paper
• Minimally modified low density lipoprotein is biologically active in vivo in mice.

  1991cited by this paper
• A NEW RESPIRATORY TRACT PATHOGEN: CHLAMYDIA PNEUMONIAE STRAIN TWAR

  1990cited by this paper
• Granulocyte-mediated injury to herpes simplex virus-infected human endothelium.

  1989cited by this paper
• Association between dental health and acute myocardial infarction.

  1989cited by this paper
• Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis.

  1989cited by this paper
• Regulation of Major Histocompatibility Gene Expression in Human Vascular Smooth Muscle Cells

  1989cited by this paper
• Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

  1988cited by this paper
• Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis.

  1987cited by this paper

• Entwicklung eines Soft-Plaque-Phantoms für die Simulation koronarer atherosklerotischer Ablagerungen in der Mehrschichtcomputertomografie

  2011cites this paper
• Genpolymorphismen als prädiktive Marker zur Vorhersage für die Entstehung der Koronaren Herzerkrankung

  2007influential citation